Cargando…
Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
The efficacy and specificity of treatment are major challenges for cancer gene therapy. Oncolytic virotherapy is an attractive drug delivery platform for cancer gene therapy. In the present study, the dual-specific antitumor oncolytic adenovirus, Ad-Apoptin-hTERT-E1a, was used to infect SW1116 human...
Autores principales: | YANG, GUOHUA, MENG, XIANGWEI, SUN, LILI, HU, NINGNING, JIANG, SHUANG, SHENG, YUAN, CHEN, ZHIFEI, ZHOU, YE, CHEN, DEXING, LI, XIAO, JIN, NINGYI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280958/ https://www.ncbi.nlm.nih.gov/pubmed/25574193 http://dx.doi.org/10.3892/etm.2014.2086 |
Ejemplares similares
-
Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014) -
Synergistic antitumor effect of the combination of a dual cancer-specific oncolytic adenovirus and cisplatin on lung cancer cells
por: Jin, Jing, et al.
Publicado: (2018) -
Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo
por: Xiao, Li, et al.
Publicado: (2010) -
Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells
por: Li, Wenjie, et al.
Publicado: (2020) -
Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)